TEVA PHARMA B.V., UTRECHT, THE NETHERLANDS - search results

gemcitabine teva 40mg/ml concentrate for solution for infusion

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - gemcitabine - concentrate for solution for infusion - gemcitabine - antineoplastic agents

European Union - English - EMA (European Medicines Agency)

leflunomide teva

teva pharma b.v. - leflunomide - arthritis, rheumatoid - immunosuppressants - leflunomide is indicated for the treatment of adult patients with active rheumatoid arthritis as a 'disease-modifying antirheumatic drug' (dmard).recent or concurrent treatment with hepatotoxic or haematotoxic dmards (e.g. methotrexate) may result in an increased risk of serious adverse reactions; therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects.moreover, switching from leflunomide to another dmard without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.

European Union - English - EMA (European Medicines Agency)

rivastigmine teva

teva pharma b.v. - rivastigmine - dementia; alzheimer disease; parkinson disease - anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.